98 related articles for article (PubMed ID: 1338677)
21. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance and the problems of HCV antibody].
Yano M
Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
[No Abstract] [Full Text] [Related]
23. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
[TBL] [Abstract][Full Text] [Related]
25. [Post-transfusion viral hepatitis].
Katayama T
Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
[No Abstract] [Full Text] [Related]
26. [Hepatitis C virus].
Garassini MA
G E N; 1990; 44(1):67-70. PubMed ID: 1967084
[No Abstract] [Full Text] [Related]
27. Managing chronic hepatitis C virus infection.
Lau JY; Davis GL
BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
[No Abstract] [Full Text] [Related]
28. [Hepatitis C].
Lissen E; Pineda JA
Enferm Infecc Microbiol Clin; 1991; 9(6):320-2. PubMed ID: 1657206
[No Abstract] [Full Text] [Related]
29. Transmission of HCV by organ transplantation.
Eggen BM; Nordbø SA
N Engl J Med; 1992 Feb; 326(6):411; author reply 412-3. PubMed ID: 1309597
[No Abstract] [Full Text] [Related]
30. [Hepatitis C virus].
Roggendorf M; Schlipköter U
Beitr Infusionsther; 1991; 28():13-21. PubMed ID: 1725610
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis C; current developments in diagnosis and therapy].
Willems M; Moshage H; Fevery J; Yap SH
Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
[No Abstract] [Full Text] [Related]
32. Hepatitis C virus updated.
Sherlock S; Dusheiko G
Gut; 1991 Sep; 32(9):965-7. PubMed ID: 1655592
[No Abstract] [Full Text] [Related]
33. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
[No Abstract] [Full Text] [Related]
34. Hepatitis C virus: implications to pediatric practice.
A-Kader HH; Balistreri WF
Pediatr Infect Dis J; 1993 Oct; 12(10):853-66; quiz 867. PubMed ID: 8284123
[No Abstract] [Full Text] [Related]
35. Non-A, non-B hepatitis: impact of the emergence of the hepatitis C virus.
Hsia PC; Seeff LB
Adv Intern Med; 1992; 37():197-222. PubMed ID: 1313633
[No Abstract] [Full Text] [Related]
36. Review of hepatitis C in Japan.
Kiyosawa K; Furuta S
J Gastroenterol Hepatol; 1991; 6(4):383-91. PubMed ID: 1717034
[No Abstract] [Full Text] [Related]
37. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.
Marcellin P; Pouteau M; Benhamou JP
J Hepatol; 1995 Mar; 22(3):364-9. PubMed ID: 7608489
[No Abstract] [Full Text] [Related]
38. The clinical virology of hepatitis C virus.
Irving WL
Int J Exp Pathol; 1994 Apr; 75(2):61-9. PubMed ID: 8199006
[No Abstract] [Full Text] [Related]
39. Basal core-IgM antibodies to hepatitis C virus are not predictive of successful alpha-interferon therapy.
Caporaso N; Tuccillo C; Morisco F
J Hepatol; 1995 Mar; 22(3):377. PubMed ID: 7608491
[No Abstract] [Full Text] [Related]
40. Hepatitis C. A clinical update.
Colquhoun SD
Arch Surg; 1996 Jan; 131(1):18-23. PubMed ID: 8546572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
